Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Otonomy Hears Wall Street Ovation as Some Life Sciences IPOs Dim

August 13, 2014 – 4:23 pm | Edit Post
Otonomy Hears Wall Street Ovation as Some Life Sciences IPOs Dim

Auris Medical, the Swiss biotech focused on diseases and disorders of the ear, got the catchy ticker symbol (NASDAQ: EARS) when it went public last week. But San Diego’s Otonomy (NASDAQ: OTIC)…

[[Click headline to continue reading.]]

Otonomy Hears Wall Street Ovation as Some Life Sciences IPOs Dim

August 13, 2014 – 4:23 pm | Edit Post
Otonomy Hears Wall Street Ovation as Some Life Sciences IPOs Dim

Auris Medical, the Swiss biotech focused on diseases and disorders of the ear, got the catchy ticker symbol (NASDAQ: EARS) when it went public last week. But San Diego’s Otonomy (NASDAQ: OTIC)…

[[Click headline to continue reading.]]

Shares Rise After Otonomy’s $100M IPO

August 13, 2014 – 4:08 pm | Edit Post

Shares of Otonomy Inc. were rising Aug. 13 after the biotech drug developer’s initial public offering raised $100 million.

New Blood: Tracing the Beginnings of Hematopoietic Stem Cells

August 13, 2014 – 2:36 pm | Edit Post
New Blood: Tracing the Beginnings of Hematopoietic Stem Cells

In a paper published online this week in Nature, researchers at the University of California, San Diego School of Medicine elaborate upon a crucial signaling pathway and the role of key proteins, which may help clear the way to generate …

Otonomy completes $100 million IPO

August 13, 2014 – 9:37 am | Edit Post

San Diego developer of ear disease drugs sells $6.25 million shares for $16 each.

Otonomy completes $100 million IPO

August 13, 2014 – 9:37 am | Edit Post

San Diego developer of ear disease drugs sells $6.25 million shares for $16 each.

Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

August 13, 2014 – 8:47 am | Edit Post
Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

San Diego-based Organovo (NYSE: ONVO) says a three-dimensional sample of living human liver tissue created with its bio-printing technology was used successfully for the first time to predict that a…

[[Click headline to continue reading.]]

Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

August 13, 2014 – 8:47 am | Edit Post
Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

San Diego-based Organovo (NYSE: ONVO) says a three-dimensional sample of living human liver tissue created with its bio-printing technology was used successfully for the first time to predict that a…

[[Click headline to continue reading.]]

Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

August 13, 2014 – 8:47 am | Edit Post
Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

San Diego-based Organovo (NYSE: ONVO) says a three-dimensional sample of living human liver tissue created with its bio-printing technology was used successfully for the first time to predict that a…

[[Click headline to continue reading.]]

Single gene controls jet lag

August 12, 2014 – 5:00 pm | Edit Post

LA JOLLA–Scientists at the Salk Institute for Biological Studies have identified a gene that regulates sleep and wake rhythms.